LOS ANGELES, CALIFORNIA–(Marketwired – June 30, 2016) –
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
Convalo Health International, Corp. (Convalo) (TSX VENTURE:CXV), a company in the addiction recovery industry in the US, today announced it has promoted Hector Rivera to Chief Financial Officer.
Mr. Rivera has been with Convalo since its founding, and previously held the position of Senior Controller. He has deep experience in the healthcare market, having spent his entire career in facilities and healthcare.
Mr. Rivera has significant experience in the mental health industry. Prior to working with Convalo, he was the Senior Controller for a large Los Angeles substance abuse company and has a deep understanding of the accounting intricacies specific to the substance abuse industry. He has a B.A. in Accounting from Cal State University, Fullerton.
“Hector has been a key asset in our accounting department, and part of Convalo since its inception,” said Dave Costine, Chairman of Convalo. “This will be a smooth transition, and I welcome Hector into his new role.”
Allan Dicks has been terminated effective immediately.
About Convalo
Convalo Health International, operating under the brand name BLVD Centers (www.blvdcenters.com), is a leader in the highly fragmented addiction rehabilitation market. Led by a seasoned executive management team with experience in US healthcare, Convalo is well positioned for continued national expansion by launching pods in cities across the US. A pod consists of a residential, detox, and mental health facility (detox facility) and an intensive outpatient (IOP) facility. Convalo, under the BLVD brand, is focused upon becoming the largest national provider of a range of mental health services, including addictive and co-occurring disorders. In conjunction with the 12-Step approach, BLVD also offers supplemental insurance-reimbursed services catering to a variety of communities: gender specific, creatively-oriented, meditation/mindfulness, trauma and LGBT affirmative.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Edward Brann
Corporate Advisor
(323) 844-1298
investorinfo@convalohealth.com
www.convalohealth.com